Current Funding Opportunities

Through our research program, Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients. We’re focused on conquering metastatic and aggressive breast cancers, advancing personalized breast care and eliminating breast cancer disparities and inequities. Our goal is to improve breast health care and outcomes for everyone and save lives.

Each year, we release Request for Applications (RFA) to communicate which grant mechanisms and scientific focus areas are available for funding. The types of mechanisms and the scientific focus areas may vary from year to year. Our latest research funding opportunities will be posted below as they become available.

Komen Application and Review Process

For Career Transition Awards (CTA) and Career Catalyst Research (CCR), Susan G. Komen® utilizes a multi-step approach to grant application and review that first requires submission of a Letter of Intent (LOI) and upon invitation only, submission of an Application.  Applicants/PIs will be notified of LOI review decisions via email. Applicants/PIs invited to submit an Application will then be granted access to the Application site in proposalCENTRAL.  

For A Supplement to Promote Inclusion for Research Excellence (ASPIRE), Susan G. Komen® accepts Applications in a single-step process.

Applicants will be notified of intent to fund on or around April 15, 2025. All institutions must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants. A copy of the latest version of these awards is found with the other documents for the LOI or Application in proposalCENTRAL. 

Click on the topic below to learn more about a current funding opportunity.

2025 Letter of Intent (LOI) Announcement

• LOI Announcement Release Date: April 15, 2025
• LOI Submission Deadline: May 23, 2025 at 1:00 pm EST
• Invitation to Submit an Application: June 16, 2025

SUSAN G. KOMEN-LOBULAR BREAST CANCER ALLIANCE METASTATIC INVASIVE LOBULAR CARCINOMA RESEARCH GRANT, IN HONOR OF JULIA K. LEVINE 

This grant mechanism will provide critical funding to support innovative research focused on metastatic invasive lobular carcinoma (mILC) that will unlock new knowledge about metastatic lobular breast cancer, advance patient care and/or improve patient outcomes of those impacted by mILC.

Award amount: $400,000 combined direct and indirect costs; ($200,000 per year for up to 2 years)

Eligibility: Independent investigators working at non-profit institutions and organizations. Researchers with a formal offer letter that confirms an independent position and start date by the Application due date (August 11, 2025) are also eligible. Non-U.S. institutions and individuals must be able to accept wire transfers and pass the non-U.S. grantee vetting process should they be selected for funding. Non-U.S. institutions and individuals on the OFAC sanctions list are ineligible to apply.

RFA Focus Area: This grant mechanism supports outstanding research with a specific primary focus on metastatic lobular breast cancer. We are especially interested in hypothesis-driven studies that will expand our understanding of the biology of mILC, and/or improve diagnosis, treatment and/or prevention of mILC. These studies may be considered basic, translational, clinical and/or population science in nature. Given that there has been so little study of lobular breast cancer, we encourage applicants to build ground-breaking paradigms, test imaginative hypotheses and develop creative concepts that may advance the current prevailing theories or practices for other breast cancer types and/or explore novel areas of investigation.

Download the current Susan G. Komen-Lobular Breast Cancer Alliance Metastatic Invasive Lobular Carcinoma Research Grant, In Honor of Julia K. Levine LOI Announcement for more details .

Susan G. Komen-Lobular Breast Cancer Alliance Metastatic Invasive Lobular Carcinoma Research Grant, In Honor of Julia K. Levine Review Process

Susan G. Komen® utilizes a multi-step approach to grant application and review that first requires submission of a Letter of Intent and upon invitation only, submission of an Application.

Applicants/PIs will be notified of Letter of Intent review decisions via email. Applicants/PIs invited to submit an Application will then be provided Application Instructions.

All institutions and industry partners must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants.